BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 18177217)

  • 1. Clinical recognition and diagnosis of Clostridium difficile infection.
    Bartlett JG; Gerding DN
    Clin Infect Dis; 2008 Jan; 46 Suppl 1():S12-8. PubMed ID: 18177217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Six years evaluation of Clostridium difficile associated diarrhea].
    Ercis S; Ergin A; Hasçelik G
    Mikrobiyol Bul; 2004; 38(1-2):45-50. PubMed ID: 15293901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods].
    Altindiş M; Usluer S; Ciftçi H; Tunç N; Cetinkaya Z; Aktepe OC
    Mikrobiyol Bul; 2007 Jan; 41(1):29-37. PubMed ID: 17427550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ["Second look" at cytotoxin B of Clostridium difficile in the course of diarrhea associated with antibiotic therapy].
    Sednaoui P; el Mantih B; Cauwell M
    Pathol Biol (Paris); 1999 May; 47(5):415-21. PubMed ID: 10418011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of four methods for detection of Clostridium difficile or C. difficile toxin: cytotoxin assay, culture, latex agglutination, and a new rapid immunoassay (C. difficile toxin A test).
    Fille M; Larcher C; Dierich MP; Allerberger F
    Z Gastroenterol; 1998 Feb; 36(2):143-9. PubMed ID: 9544497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clostridium difficile diarrhea: frequency of detection in a medical center in Buenos Aires, Argentina].
    Fernandez Canigia L; Nazar J; Arce M; Dadamio J; Smayevsky J; Bianchini H
    Rev Argent Microbiol; 2001; 33(2):101-7. PubMed ID: 11494752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.
    Bauer MP; Veenendaal D; Verhoef L; Bloembergen P; van Dissel JT; Kuijper EJ
    Clin Microbiol Infect; 2009 Dec; 15(12):1087-92. PubMed ID: 19624512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors].
    Tunçcan OG; Ulutan F; Karakuş R
    Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlation of toxin and common antigen enzyme immunoassay testing in patients with Clostridium difficile disease.
    Lee SD; Turgeon DK; Ko CW; Fritsche TR; Surawicz CM
    Am J Gastroenterol; 2003 Jul; 98(7):1569-72. PubMed ID: 12873579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridium difficile in adult patients with nosocomial diarrhea in a Costa Rican hospital.
    Zumbado-Salas R; Gamboa-Coronado Mdel M; Rodríguez-Cavallini E; Chaves-Olarte E
    Am J Trop Med Hyg; 2008 Aug; 79(2):164-5. PubMed ID: 18689617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clostridium difficile infection in children--experience of clinical centre in Bydgoszcz].
    Duleba K; Smukalska E; Pawłowska M
    Przegl Epidemiol; 2012; 66(1):67-71. PubMed ID: 22708301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clostridium difficile colitis: a review.
    Moudgal V; Sobel JD
    Hosp Pract (1995); 2012 Feb; 40(1):139-48. PubMed ID: 22406889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].
    Nurzyńska G; Pituch H; Kamola R; Kopeć ES
    Med Dosw Mikrobiol; 2013; 65(4):263-8. PubMed ID: 24730214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection.
    Nemat H; Khan R; Ashraf MS; Matta M; Ahmed S; Edwards BT; Hussain R; Lesser M; Pekmezaris R; Dlugacz Y; Wolf-Klein G
    Am J Gastroenterol; 2009 Aug; 104(8):2035-41. PubMed ID: 19367273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.
    Massey V; Gregson DB; Chagla AH; Storey M; John MA; Hussain Z
    Am J Clin Pathol; 2003 Jan; 119(1):45-9. PubMed ID: 12520696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clostridium difficile and diarrhea associated with the use of antibiotics in the origin of nosocomial and community-acquired diarrhea].
    Knobel H; Salvado M; Segura C
    Enferm Infecc Microbiol Clin; 1996 Feb; 14(2):96-100. PubMed ID: 8714156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to identify the cause of antibiotic-associated diarrhea.
    Bartlett JG
    J Crit Illn; 1994 Dec; 9(12):1063-7. PubMed ID: 10150699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of Clostridium difficile-associated intestinal disease.
    Rolfe RD
    Crit Rev Clin Lab Sci; 1986; 24(3):235-61. PubMed ID: 3539522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea.
    Raveh D; Rabinowitz B; Breuer GS; Rudensky B; Yinnon AM
    Int J Antimicrob Agents; 2006 Sep; 28(3):231-7. PubMed ID: 16908119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.